TabletAnti HIV

Lamivudine & Zidovudine Tablets

Lamivudine + Zidovudine · Antiretroviral fixed-dose combination (NRTIs)

TabletAnti HIV

Lamivudine & Zidovudine TabletsProspero Healthcare

Lamivudine + Zidovudine is presented as fixed-dose combination tablets and belongs to the class of antiretroviral fixed-dose combination (NRTIs). Its standard indications include hIV-1 infection, as determined by a prescribing clinician.

Uses

HIV-1 infection

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Lamivudine + Zidovudine
Available strengthsIndicative: 150 mg + 300 mg
Dosage form: Tablet
Therapeutic category: Anti HIV Anti Viral Anti Hepatitis
Therapeutic class: Antiretroviral fixed-dose combination (NRTIs)
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category